Clinical Trial Update: Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating Carraguard vaginal gel to prevent HIV transmission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Carraguard

Snippet

Sponsor: Population Council | Conditions: HIV Infections, AIDS | Phase 3 | Status: COMPLETED